These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32698143)

  • 1. Gut-liver axis modulation in fructose-fed mice: a role for PPAR-alpha and linagliptin.
    Silva-Veiga FM; Miranda CS; Martins FF; Daleprane JB; Mandarim-de-Lacerda CA; Souza-Mello V
    J Endocrinol; 2020 Oct; 247(1):11-24. PubMed ID: 32698143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha activation and dipeptidyl peptidase-4 inhibition target dysbiosis to treat fatty liver in obese mice.
    Silva-Veiga FM; Miranda CS; Vasques-Monteiro IML; Souza-Tavares H; Martins FF; Daleprane JB; Souza-Mello V
    World J Gastroenterol; 2022 May; 28(17):1814-1829. PubMed ID: 35633911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rise in Proteobacteria is an indicator of gut-liver axis-mediated nonalcoholic fatty liver disease in high-fructose-fed adult mice.
    Vasques-Monteiro IML; Silva-Veiga FM; Miranda CS; de Andrade Gonçalves ÉCB; Daleprane JB; Souza-Mello V
    Nutr Res; 2021 Jul; 91():26-35. PubMed ID: 34130208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice.
    Olivares M; Neyrinck AM; Pötgens SA; Beaumont M; Salazar N; Cani PD; Bindels LB; Delzenne NM
    Diabetologia; 2018 Aug; 61(8):1838-1848. PubMed ID: 29797022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice.
    Iwamoto Y; Kimura T; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nogami Y; Shirakiya Y; Nakanishi S; Mune T; Kaku K; Kaneto H
    Diabetes Obes Metab; 2024 Jun; 26(6):2339-2348. PubMed ID: 38504118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-α activation counters brown adipose tissue whitening: a comparative study between high-fat- and high-fructose-fed mice.
    Miranda CS; Silva-Veiga F; Martins FF; Rachid TL; Mandarim-De-Lacerda CA; Souza-Mello V
    Nutrition; 2020 Oct; 78():110791. PubMed ID: 32682271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment.
    Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I
    Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Glucose or -Fructose Diet Cause Changes of the Gut Microbiota and Metabolic Disorders in Mice without Body Weight Change.
    Do MH; Lee E; Oh MJ; Kim Y; Park HY
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29899272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice.
    Lebrun V; Molendi-Coste O; Lanthier N; Sempoux C; Cani PD; van Rooijen N; Stärkel P; Horsmans Y; Leclercq IA
    Clin Sci (Lond); 2013 Dec; 125(11):501-11. PubMed ID: 23758436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance.
    Ren LP; Chan SM; Zeng XY; Laybutt DR; Iseli TJ; Sun RQ; Kraegen EW; Cooney GJ; Turner N; Ye JM
    PLoS One; 2012; 7(2):e30816. PubMed ID: 22355328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis.
    Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F
    J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
    Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice.
    Vasques-Monteiro IML; Fernandes-da-Silva A; Miranda CS; Silva-Veiga FM; Daleprane JB; Souza-Mello V
    Mol Cell Endocrinol; 2024 May; 585():112177. PubMed ID: 38373652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice.
    Feng D; Zhang H; Jiang X; Zou J; Li Q; Mai H; Su D; Ling W; Feng X
    Environ Pollut; 2020 Oct; 265(Pt A):114880. PubMed ID: 32540565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice.
    Santos FO; Correia BRO; Marinho TS; Barbosa-da-Silva S; Mandarim-de-Lacerda CA; Souza-Mello V
    Mol Cell Endocrinol; 2020 Jun; 509():110804. PubMed ID: 32259637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.
    Chan SM; Sun RQ; Zeng XY; Choong ZH; Wang H; Watt MJ; Ye JM
    Diabetes; 2013 Jun; 62(6):2095-105. PubMed ID: 23349482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
    Shirakawa J; Fujii H; Ohnuma K; Sato K; Ito Y; Kaji M; Sakamoto E; Koganei M; Sasaki H; Nagashima Y; Amo K; Aoki K; Morimoto C; Takeda E; Terauchi Y
    Diabetes; 2011 Apr; 60(4):1246-57. PubMed ID: 21330637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linagliptin improves insulin sensitivity and hepatic steatosis in diet-induced obesity.
    Kern M; Klöting N; Niessen HG; Thomas L; Stiller D; Mark M; Klein T; Blüher M
    PLoS One; 2012; 7(6):e38744. PubMed ID: 22761701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.